Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data
Publication
Release Date:
Citation
AIHW
Australian Institute of Health and Welfare (2022) Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data, AIHW, Australian Government, accessed 18 September 2024. doi:10.25816/hm5d-s745
APA
Australian Institute of Health and Welfare. (2022). Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data. Canberra: AIHW. doi:10.25816/hm5d-s745
MLA
Australian Institute of Health and Welfare. Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data. AIHW, 2022. doi:10.25816/hm5d-s745
Vancouver
Australian Institute of Health and Welfare. Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data. Canberra: AIHW; 2022. doi:10.25816/hm5d-s745
Harvard
Australian Institute of Health and Welfare 2022, Medication use for secondary prevention after coronary heart disease hospitalisations: Patient pathways using linked data, AIHW, Canberra. doi:10.25816/hm5d-s745
PDF | 2.7Mb
This project used the National Integrated Health Services Information Analysis Asset to explore factors that affect medication use among 67,800 people who were hospitalised for coronary heart disease. It found that younger patients and women were among those people less likely to be dispensed cardiovascular medicines and to still be taking them 1 year after leaving hospital. This information may inform strategies to improve medication use among these groups.
- ISBN: 978-1-922802-21-7
- DOI: 10.25816/hm5d-s745
- Cat. no: CVD 98
- Pages: 56
Findings from this report:
-
61% of people with acute coronary syndrome initiated ≥3 of the 4 classes of CVD medicines within 40 days of discharge
-
Women and people aged under 65 were less likely to be dispensed the recommended medicines following hospitalisation
-
3 in 4 patients were still taking their medicines 1 year after leaving hospital
-
Contact with community-based health care services was associated with use of recommended CVD medicines